MasterClass – GCP (Good Clinical Practice): Investigator and sponsor responsibilities
Useful informations
Location: Room 1-2 and online
Price : Free
20 october 2022 - 10:00 to 12:00
Quantity : 25 seats
Registration deadline :19 october 2022
⚠️ Registration is closed for the moment, you can pre-register to be notified of the next edition
This MasterClass will be held in French 🇫🇷
This MasterClass will be held in French 🇫🇷
Description
When setting up a clinical trial (clinical evaluation of a medical device or drug), the responsibilities related to the management and monitoring of the trial are divided between the investigators and the sponsor. This training will give you a global vision of “who does what and how” in compliance with Good Clinical Practice (GCP).
This training is aimed at researchers and/or start-up actors (biotech, medtech or digital) who will be – in the short, medium or long term – required to carry out clinical trials as part of their research or as part of the development of a drug or medical device.
Prerequisites: no
For further information: mga@icm-institute.org
What you will learn
Participants will be able to position themselves in :
- Become familiar with “Good Clinical Practice (GCP)
- Know the ethical principles of clinical research
- Understand the role and responsibilities of the sponsor and the investigator
- Be familiar with the regulations and vigilance in clinical research
- Be familiar with the use of data and the respect of the European Data Protection Regulation (RGPD)
Content of the training
- Good Clinical Practice (GCP)
- Background
- Ethical principles and clinical research
- Definition and role of the sponsor
- Definition of the investigator
- Regulations
- Responsibilities of the investigator and sponsor
- Sanctions
- Vigilance
- RGPD
Teaching team
Ressources
- The training material in pdf format
- Useful links to go further